Fax: +46-8-314957.
1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
Epidemiology
You have full text access to this OnlineOpen article
Predictors of ovarian cancer survival: A population-based prospective study in Sweden
Article first published online: 22 MAY 2008
DOI: 10.1002/ijc.23429
Copyright © 2008 Wiley-Liss, Inc.
Additional Information
How to Cite
Yang, L., Klint, Å., Lambe, M., Bellocco, R., Riman, T., Bergfeldt, K., Persson, I. and Weiderpass, E. (2008), Predictors of ovarian cancer survival: A population-based prospective study in Sweden. Int. J. Cancer, 123: 672–679. doi: 10.1002/ijc.23429
- †
Fax: +46-8-314957.
Publication History
- Issue published online: 28 MAY 2008
- Article first published online: 22 MAY 2008
- Manuscript Accepted: 14 DEC 2007
- Manuscript Received: 14 SEP 2007
Funded by
- Swedish Cancer Society
- Gustav V Jubilee Foundation in Sweden
References
- 1,,,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108.
- 2,. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006; 20: 207–25.
- 3,. Ovarian cancer. In: AdamiH,HunterD,TrichopoulosD, eds. Textbook of cancer epidemiology. Oxford: Oxford University Press, 2002: 378–99.
- 4,,. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) 1998; 49: 695–707.
- 5,,. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 2004; 83: 783–95.
- 6,,. Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol Oncol 2004; 95: 215–25.
- 7,,,,,,. Risk factors for epithelial borderline ovarian tumours: results of a Swedish case-control study. Gynecol Oncol 2001; 83: 575–85.
- 8,,,,,,. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 2002; 156: 363–73.
- 9,,,. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk. Cancer Detect Prev 2005; 29: 129–32.
- 10. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 2003; 164: 371–7.
- 11VainioH,BianchiniF. eds. International Agency for Research on Cancer. Weight control and physical activity. In: IARC handbooks of cancer prevention. Lyon: IARC Press, 2002; 95–154.
- 12,,,,,,,. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 2002; 94: 497–504.
- 13,,,,,. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 2004; 19: 1011–19.
- 14,,,,,. Age at natural menopause and the risk of epithelial ovarian cancer. Obstet Gynecol 2001; 98: 85–90.
- 15,,,,,,. Prospective study of physical activity in different periods of life and the risk of ovarian cancer. Int J Cancer 2006; 118: 3153–60.
- 16,,,,. A prognostic model for ovarian cancer. Br J Cancer 2001; 85: 944–52.
- 17,,. Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner? Ann Oncol 1999; 10( Suppl 1): 9–15.
- 18,. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 2000; 19: 3–10.
- 19,,,. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 2003; 101: 885–91.
- 20,,. Reproductive factors and survival from ovarian cancer. Int J Cancer 1993; 54: 904–6.
- 21,,,,,,,. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 798–803.
- 22,,,,,,. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival. Int J Cancer 2006; 119: 2907–15.
- 23,,,,. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002; 11: 822–8.
- 24,,. Mortality in relation to oral contraceptive use and cigarette smoking. Lancet 2003; 362: 185–91.
- 25,,,,. Body mass index in relation to ovarian cancer survival. Cancer Epidemiol Biomarkers Prev 2005; 14: 1307–10.
- 26,,,,. Survival of BRCA1 negative ovarian cancer patients based on family history. Gynecol Oncol 2001; 83: 109–14.
- 27,,,,,,,,,. Survival analysis in familial ovarian cancer, a case control study. Eur J Obstet Gynecol Reprod Biol 2001; 98: 219–23.
- 28,,,,,. Do risk factors for epithelial ovarian cancer have an impact on prognosis? Focus on previous pelvic surgery and reproductive variables. Eur J Gynaecol Oncol 2006; 27: 467–72.
- 29,,,,,,. Effect of obesity on survival in epithelial ovarian cancer. Cancer 2006; 107: 1520–4.
- 30,,. Cigarette smoking and survival after ovarian cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2006; 15: 2557–60.
- 31,. Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr 2002; 132: 3504S–3507S.
- 32,,,,,,. Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 1998; 76: 29–34.
- 33,. Modelling survival data: extending the Cox model. New York: Springer, 2000.
- 34Stata Statistical Software: Release 9. StataCorp. College Station, TX: StataCorp LP, 2005.
- 35,,,,,,. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001; 82: 532–7.